Analytical and biological variation in measures of anemia and iron status in patients treated with maintenance hemodialysis

American Journal of Kidney Diseases

Volumn 56, Issue 3, 2010, Pages 540-546

  Van Wyck, David B ^a   Alcorn Jr , Harry ^b   Gupta, Resmi ^c  

^a DAVITA INC   (United States)

^b DAVITA CLINICAL RESEARCH   (United States)

^c Vital Systems Inc   (United States)

Author keywords

Laboratory variation; reticulocyte hemoglobin

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; IRON THERAPY; MAINTENANCE THERAPY; MALE; MEASUREMENT; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; OBSERVER VARIATION; PROBABILITY; PROSPECTIVE STUDY; RETICULOCYTE HEMOGLOBIN CONTENT; THERAPY EFFECT; TRANSFERRIN BLOOD LEVEL; TREATMENT DURATION; BLOOD; LONGITUDINAL STUDY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ANEMIA; FEMALE; HUMANS; IRON; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 77956225517     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.05.009     Document Type: Article

References (15)

1. E. Lacson Jr, N. Ofsthun, and J.M. Lazarus Effect of variability in anemia management on hemoglobin outcomes in ESRD Am J Kidney Dis 41 1 2003 111 124
2. S. Fishbane, and J.S. Berns Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin Kidney Int 68 3 2005 1337 1343
3. J.S. Berns, H. Elzein, R.I. Lynn, S. Fishbane, I.S. Meisels, and P.B. Deoreo Hemoglobin variability in epoetin-treated hemodialysis patients Kidney Int 64 4 2003 1514 1521
4. D.M. Spiegel Hemoglobin variability in chronic kidney disease: a cross-sectional study Am J Med Sci 337 5 2009 340 343
5. N.C. Boudville, O. Djurdjev, and I.C. Macdougall Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortality Clin J Am Soc Nephrol 4 7 2009 1176 1182
6. G. Casale, A. Migliavacca, C. Bonora, I.E. Zurita, and P. de Nicola Circadian rhythm of plasma iron, total iron binding capacity and serum ferritin in arteriosclerotic aged patients Age Ageing 10 2 1981 115 118
7. J.C. Dale, M.F. Burritt, and A.R. Zinsmeister Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels Am J Clin Pathol 117 5 2002 802 808
8. A. Belza, A.K. Ersboll, M. Henriksen, S.H. Thilsted, and I. Tetens Day-to-day variation in iron-status measures in young iron-deplete women Br J Nutr 94 4 2005 551 556
9. C.G. Fraser Biological Variation: From Principles to Practise 2001 AACC Press Washington DC
10. P.P. Basiotis, S.O. Welsh, F.J. Cronin, J.L. Kelsay, and W. Mertz Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence J Nutr 117 9 1987 1638 1641
11. P.C. Adams, D.M. Reboussin, and R.D. Press Biological variability of transferrin saturation and unsaturated iron-binding capacity Am J Med 120 11 2007 999 e1-e7
12. B.A. Ford, D.W. Coyne, C.S. Eby, and M.G. Scott Variability of ferritin measurements in chronic kidney disease; implications for iron management Kidney Int 75 1 2009 104 110
13. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease Am J Kidney Dis 47 suppl 3 2006 S11 S145
14. T. Akizawa, R.L. Pisoni, and T. Akiba Japanese haemodialysis anaemia management practices and outcomes (1999-2006): results from the DOPPS Nephrol Dial Transplant 23 11 2008 3643 3653
15. C.G. Fraser Biological variation data for setting quality specifications http://www.westgard.com/site-map-2.htm Accessed June 2, 2010